Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.9640
-0.0560 (-5.49%)
Apr 15, 2026, 4:59 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 41.64 million as of April 15, 2026. Its market cap has increased by 382.44% in one year.
Market Cap
41.64M
Enterprise Value
40.07M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.96
Market Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 41.64M, a decrease of -87.26%. That is a compound annual growth rate of -29.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 44.06M | -31.08% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.06T |
| Genmab | 113.14B |
| Coloplast | 96.78B |
| ALK-Abelló | 47.68B |
| Gubra | 5.49B |
| BioPorto | 442.63M |
| Pharma Equity Group | 104.59M |
| ViroGates | 101.17M |